Clinical trial
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At…
NCT00403078 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00403078 |
|---|---|
| Title | SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy |
| Official title | Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide) |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Carotid Artery Disease |
| Enrollment | 21,008 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 1, 2014 |
| Completion | Nov 1, 2014 |
| First posted | Nov 23, 2006 |
| Last update posted | Aug 10, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: